Skip to main content
Premium Trial:

Request an Annual Quote

Stephen Oldfield, Gustavo Salem, Beckman Coulter, Acolyte Biomedica

Premium

Migrations

ForteBio recently named Stephen Oldfield to the new position of vice president of marketing and sales.

Oldfield joined ForteBio in early August from Molecular Devices, where he was vice president of worldwide marketing. He will be responsible for recruiting marketing and sales personnel in support of ForteBio's first product launch later this year, ForteBio said. Prior to his employment with Molecular Devices, Oldfield held senior marketing positions at Molecular Probes, FMC BioProducts, Molecular Dynamics, and Pharmacia Biotechnology AB. Oldfield received a PhD in pure and applied biology from the Imperial College, London, and a BS in genetics from the University of Sheffield in the UK.


Assay Designs has appointed Gustavo Salem as its new president and CEO, the Ann Arbor, Mich.-based biotech firm said last week.

Prior to joining Assay Designs, Salem held a variety of positions at Bio-Rad Laboratories, including division manager of protein separations and business unit manager for biomaterials. Prior to this, he held a series of sales and marketing positions at PerSeptive Biosystems, Beckman Instruments, and Amersham.

 

Products

Beckman Coulter last week introduced the IOTest Anti-Cyclin A2 monoclonal antibody for the study of cell-cycle transitions in life science research.

The FITC-conjugated antibody is the newest addition to Beckman's universal cytometry reagent line, which works on all instrument platforms, including the company's Cell Lab Quanta and FC 500 MPL flow cytometers, Beckman said. The new antibody is useful in a wide range of applications such as basic research on cell cycle control; apoptosis and tumorigenesis; clinical cancer studies; and pharmaceutical discovery to identify inhibitors, blockers, and anti-mitotic drugs, Beckman said.


Acolyte Biomedica has expanded its BacLite RapiTECT kits to include a mammalian cell enumeration assay, the UK-based company said last week.

The BacLite RapiTECT M uses the Acolyte Biomedica AK Rapid technology, in which adenylate kinase is used as a highly sensitive marker to measure mammalian cells, Acolyte said. The development is being undertaken in collaboration with Barbara Reeves, an cellular and molecular biology professor at the University of Bath.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.